# Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma

> **NCT00575887** · PHASE2 · COMPLETED · sponsor: **Marmara University** · enrollment: 25 (actual)

## Conditions studied

- Glioblastoma
- Astrocytoma
- Oligodendroglioma
- Brain Tumor, Recurrent

## Interventions

- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT00575887
- **Lead sponsor:** Marmara University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575887, "Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00575887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*